Dopamine Reuptake Inhibitors of Cocaine Abuse - 1

ClinicalTrials.gov ID: NCT00000276

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00000276. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Dopamine Reuptake Inhibitors of Cocaine Abuse

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate dopamine reuptake inhibitors for cocaine abuse.

Study identification

NCT ID: NCT00000276
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 1
Lead sponsor: Yale University; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Cocaine-Related Disorders

Interventions

Bupropion Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 45 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 1994 (Type not available)
Primary completion: Aug 1999 (Actual)
Completion: Aug 1999 (Actual)
Last update posted: Jun 18, 2020

1994 – 1999

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
VA Connecticut Healthcare System	New Haven	Connecticut	06519	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00000276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 18, 2020 · Synced Nov 15, 2026